Psychedelic-assisted therapy

This page covers all Psychedelic-assisted therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT2A receptor.

Targets

5-HT2A receptor

Phase 3 pipeline (1)

• CYB003 · Cybin IRL Limited · Psychiatry/Mental Health
  CYB003 is a psilocybin-assisted therapy designed to enhance psychological treatment outcomes in psychiatric conditions by facilitating neuroplasticity and emotional processing.

Patent intelligence

• psychedelic assisted therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates